Toll-like receptor 2 ligands as adjuvants for human Th1 responses

被引:85
|
作者
Sieling, PA
Chung, W
Duong, BT
Godowski, PJ
Modlin, RL
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol & Immunol, Div Dermatol, Los Angeles, CA 90095 USA
[2] Genentech Inc, San Francisco, CA 94080 USA
来源
JOURNAL OF IMMUNOLOGY | 2003年 / 170卷 / 01期
关键词
D O I
10.4049/jimmunol.170.1.194
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bacterial lipopeptides (bLPs) are increasingly used as adjuvants to activate cell-mediated immune responses to foreign Ags. To explore mechanisms whereby bLPs adjuvant T cell responses, we stimulated human PBMCs with bLPs. We found that bLPs stimulate T cells to proliferate and produce IFN-gamma in an accessory cell-dependent manner and in the absence of exogenous protein Ags. The ability of bLPs to stimulate T cell proliferation was Toll-like receptor 2 dependent and required IL-12, interaction with costimulatory molecules, and MHC proteins. Our data suggest that bLPs adjuvant adaptive Th1 responses by enhancing Ag presentation of endogenous peptides.
引用
收藏
页码:194 / 200
页数:7
相关论文
共 50 条
  • [21] Toll-like receptor ligands and their combinations as adjuvants - current research and its relevance in chickens
    Gupta, S. K.
    Singh, L. V.
    Chellappa, M. M.
    Dey, S.
    WORLDS POULTRY SCIENCE JOURNAL, 2015, 71 (01) : 95 - 109
  • [22] Expression of Toll-like Receptor 3 and Toll-like Receptor 7 in Muscle Is Characteristic of Inflammatory Myopathy and Is Differentially Regulated by Th1 and Th17 Cytokines
    Tournadre, A.
    Lenief, V.
    Miossec, P.
    ARTHRITIS AND RHEUMATISM, 2010, 62 (07): : 2144 - 2151
  • [23] Evaluation of Lipopeptides as Toll-like Receptor 2 Ligands
    Hussein, Waleed M.
    Choi, Phil M.
    Zhang, Cheng
    Su, Mei
    Sierecki, Emma
    Johnston, Wayne
    Fagan, Vincent
    Alexandrov, Kirill
    Skwarczynski, Mariusz
    Gambin, Yann
    Toth, Istvan
    Simerska, Pavla
    CURRENT DRUG DELIVERY, 2017, 14 (07) : 935 - 943
  • [24] Simple synthetic toll-like receptor 2 ligands
    Abdel-Aal, Abu-Baker M.
    Al-Isae, Kalifa
    Zaman, Mehfuz
    Toth, Istvan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (19) : 5863 - 5865
  • [25] Expression of toll-like receptor 2 in human uterine cervical epithelial cells and their cytokine responses to toll2 ligands.
    Hyrapetian, Mariyum I.
    Newton, Susan
    Anumba, Dilly
    REPRODUCTIVE SCIENCES, 2008, 15 (02) : 189A - 190A
  • [26] Toll-like receptor 2 activation is essential to induce a TH1 shift in human PBMCs by plant sterols and plant stanols
    Brull, F.
    Mensink, R. P.
    Plat, J.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2010, 69 (OCE3) : E237 - E237
  • [27] From the Th1/Th2 paradigm towards a toll-like receptor/T-helper bias
    Netea, MG
    Van der Meer, JWM
    Sutmuller, RP
    Adema, GJ
    Kullberg, BJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (10) : 3991 - 3996
  • [28] Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
    Kirtland, Max E.
    Tsitoura, Daphne C.
    Durham, Stephen R.
    Shamji, Mohamed H.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [29] Association of a toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis
    Strle, Klemen
    Shin, Junghee J.
    Glickstein, Lisa J.
    Steere, Allen C.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (05): : 1497 - 1507
  • [30] Toll-Like Receptor Agonists as Adjuvants for HIV Vaccines
    Stevceva, L.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (33) : 5079 - 5082